Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoadsorption for coagulation factor inhibitors.

J Uehlinger1, G R Button, J McCarthy

  • 1New York Blood Center, Mount Sinai Medical Center, New York 10029.

Transfusion
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stroke recovery patterns and predictors in India: A post-hoc analysis from the ATTEND trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

In ovo sexing and genotyping using PCR techniques: a contribution to the 3R principles in chicken breeding.

Scientific reports·2026
Same author

Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates.

Vaccine·2023
Same author

Evaluation of the self-administration potential of high-density microarray patches to human skin: A preliminary study.

Human vaccines & immunotherapeutics·2023
Same author

Computed diffusion-weighted imaging in patients with transient neurovascular symptoms with and without ischemic infarction.

Journal of neuroradiology = Journal de neuroradiologie·2023
Same author

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.

PloS one·2022
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
See all related articles

This study shows extracorporeal immunoadsorption effectively lowers inhibitor levels in coagulation disorders. This allows for successful factor replacement therapy, improving hemostasis in patients with hemophilia and von Willebrand disease.

Area of Science:

  • Hematology
  • Immunology
  • Biotechnology

Background:

  • Coagulation disorders present significant management challenges, often with inadequate hemostasis from current therapies.
  • Inhibitors to coagulation factors are a primary difficulty in treating these disorders.
  • Existing treatments often fail to guarantee effective hemostasis.

Observation:

  • An extracorporeal immunoadsorption system utilizing staphylococcal protein A-Sepharose columns was employed.
  • This system selectively binds and removes immunoglobulin G (IgG), targeting inhibitor removal.
  • The procedure was performed on eight patients across ten treatment instances.

Findings:

  • The immunoadsorption system successfully reduced inhibitor levels in all six hemophilia patients and one patient with acquired von Willebrand disease.

Related Experiment Videos

  • Inhibitor levels were reduced to below 10 Bethesda units in these patients.
  • Following inhibitor reduction, patients achieved measurable factor levels upon administration of factor concentrate replacement therapy.

    • Implications:

    • Extracorporeal immunoadsorption offers an effective method for removing inhibitors in coagulation disorders.
    • This technique facilitates successful factor replacement therapy, improving treatment outcomes.
    • It presents a promising approach for managing patients with challenging inhibitor profiles.